Complex intra-host SARS-CoV-2 evolution following monoclonal antibody pre-exposure prophylaxis
Sotrovimab pre-exposure prophylaxis in an immunocompromised patient did not prevent SARS-CoV-2 infection, and was selected for resistant mutation E340D, with unexpected fitness consequences across non-receptor binding domain spike regions.